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The feasibility of using spermatogonial stem cells (SSCs) for cell-based infertility treatment has suffered from
a lack of evidence in a preclinical nonhuman primate model. In this issue, Hermann et al. (2012) demonstrate
that autologous and allogeneic transplantation of SSCs in testes of rhesus macaques produced functional
sperm.In industrialized countries, one in seven
couples experience infertility problems
(Templeton, 2000), including cases aris-
ing in some patients who were treated
for cancer. Effective doses of chemo-
therapy and radiation used for treating
children and adults with cancer are asso-
ciated with high gonadal toxicity, which
often results in subsequent infertility and
alters the quality of life for survivors. For
adult and pubescent patients, sperm is
cryopreserved prior to cancer treatment
and can be used to fertilize eggs by assis-
ted reproductive technologies (ART), like
intracytoplasmic sperm injection (ICSI).
Unlike pubertal males, no therapeutic
solution is available to restore the com-
promised fertility of prepubescent boys
after cancer treatment, because sperm
preservation is impossible. Throughout
reproductive life, spermatogenesis origi-
nates from a small pool of spermatogonial
stem cells (SSCs) that can self-renew or
differentiate to produce sperm. SSCs
are present in the prepubertal testis,
although they do not differentiate into
sperm before puberty. As a result, they
constitute a source of cells to develop
future therapy in hopes of the recovery
of fertility. Therefore, cryopreservation of
testicular fragments is now a proposed
option for prepubertal boys with cancer
in some clinics.
Different therapies for infertility prob-
lems have been considered, such as
testicular transplantation of SSCs, tissuegrafting, or in vitro culture of tissue frag-
ments, in order to produce sperm for
ICSI (Clark et al., 2011). Testicular trans-
plantation of SSCs restores functional
spermatogenesis in mouse models
(Brinster and Avarbock, 1994) and is
commonly used to identify SSCs by their
functional activity. Regeneration of
spermatogenesis after SSC transplan-
tation has been successfully reproduced
in other mammalian species (Kim et al.,
2008). However, such evidence is still
lacking in a primate model, despite
several previous attempts (Jahnukainen
et al., 2011). Preclinical assessment of
stem cell therapy in nonhuman primates
is of great significance for clinical trans-
lation in infertility treatment. In their
current study in this issue of Cell Stem
Cell, Hermann et al. demonstrate that
SSCs transplanted in testes of rhesus
macaques produced functional sperm,
which is a significant breakthrough
toward clinical translation of this line of
stem cell research (Hermann et al., 2012).
First, autologous transplantations were
performed in macaques treated with
busulfan, a commonly used chemothera-
peutic agent, in order to deplete endo-
geneous spermatogenesis. Testicular
tissue was obtained from prepubertal
and adult macaques prior to busulfan
treatment (hemicastration, biopsy) and
frozen. After busulfan chemotherapy,
testicular cells prepared from frozen
tissue were transduced with lentiviralCell Stem Cell 11,vectors expressing fluorescent proteins
in order to trace transplanted SSCs and
their progeny. Each recipient was then
transplanted with its own transduced
testicular cells. Twenty weeks after trans-
plantation, DNA typing of sperm by detec-
tion of a lentivirus-specific sequence
revealed the presence of donor-derived
sperm in the semen of 9 in 12 adult recip-
ients. Thus, transplanted SSCs colonized
the seminiferous tubules of the recipient
and differentiated. Further analyses of
the chimerism showed a transient pattern
that could reflect a low efficiency of
engraftment of the labeled donor SSC.
The same pattern of chimerismwas found
in three out of five transplanted prepu-
bertal recipients at puberty. Notably, the
reporter gene fluorescence was observed
neither in ejaculated sperm nor in the
seminiferous tubules after necropsy, sug-
gesting in vivo silencing of reporter gene
expression and/or a low labeling effi-
ciency of SSCs by lentiviral transduction.
Future work using efficient labeling of
SSCs and imaging of regeneration will
undoubtedly provide fruitful insights con-
cerning the homing of transplanted
SSCs and the expansion of the colonies
into seminiferous tubules of primate. The
low efficiency of the stem cell labeling
by lentiviral transduction decreased the
power of the functional test of SSC
transplantation. Indeed, labeled SSCs
are a minority in the whole donor SSC
population, because they are not sorted,November 2, 2012 ª2012 Elsevier Inc. 585
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for niche occupancy when transplanted in
recipient testes. To overcome this issue,
the authors hypothesized that allogeneic
transplantation, despite potential histo-
compatibility problems, would be a more
powerful tool because all SSCs from the
donor would already be detectable
through their unique DNA microsatellite
allele profile, allowing the authors to trace
donor-derived sperm.
Therefore, theauthors investigatedSSC
allogeneic transplantation performed be-
tween unrelated individuals. Donor SSCs
were transplanted in six tissue-matched
recipient macaques (with screening
based on low recipient T cell reactivity
to donor antigens), five of which were
treated with an immune suppression
regimen. In twoout of six recipients, trans-
planted SSCs produced donor-derived
sperm that were detected by micro-
satellite fingerprinting. A steady chime-
rism ranging from 1.7% to 17.2% was
observed in semen samples from one
recipient between 3 and 17 months
after transplantation. In addition, donor-
derived sperm were used to fertilize
oocytes by ICSI, and 8.6% of the em-
bryos produced displayed microsatellite
markers from donor SSCs, demonstrating
the functionality of the donor-derived
sperm. Unfortunately, they could not
transfer donor-derived embryos to surro-
gate females in order to generate healthy
offspring. This next step will be important
before considering any clinical translation
of SSC transplantation.
These findings validate the overall pro-
cedure of SSC transplantation, which
seems to be close to what might be
translated to human, and its reliability
(with 18 adult and 5 prepubertal
macaques transplanted). However, the
efficiency of spermatogenesis recovery
remains low and will need, for example,
improvements in the conditioning of
the recipient to generate empty niches.
Alternatively, the low efficiency could
also result from too few SSCs being
transplanted and/or a diminished ability
of the primate recipient niche to support586 Cell Stem Cell 11, November 2, 2012 ª2the development of transplanted SSCs
after chemotherapy conditioning, even if
data from Hermann et al. show clearly
that the recipient niche can sustain a
functional spermatogenesis (Hermann
et al., 2012). On one hand, the amplifi-
cation of SSCs in vitro should be a key
step for increasing the stem cell number
obtained from biopsy (Sadri-Ardekani
et al., 2009), even if recent work suggests
that extensive amplification can be detri-
mental to SSCs (Schmidt et al., 2011).
On the other hand, the cotransplantation
of SSCs and Sertoli cells, which are
crucial components of the testicular
niche, might help to increase the effi-
ciency of regeneration. In this regard, the
recent reprogramming of mouse skin
cells into embryonic Sertoli-like cells
seems promising as a source of cells to
nurse transplanted SSCs (Buganim
et al., 2012). In the case of cancer survi-
vors, in whom the risk of transplanting
cancer cells present in the testicular
biopsy should be strictly avoided, an
optimal method for selecting populations
of SSCs devoid of tumoral cells is a
prerequisite for clinical applications (Her-
mann et al., 2011, 2012).
Because the main function of the germ
cell lineage is to transmit genetic infor-
mation to progeny, cell therapy using
SSCs should require a higher level of
control and care compared to stem cells
from other tissue. The genetic and
epigenetic integrity of SSCs should be
highly checked in order to prevent any
hereditary risk, especially if SSCs are
amplified in vitro, and preclinical studies
in nonhuman primate model are invalu-
able for this purpose. In addition, we can
anticipate several ethical issues that may
arise in the context of future therapies.
It is somewhat surprising that the allo-
genic transplantation provided the proof
of concept for this therapeutic approach,
but it also highlights a potential alternative
method of restoring fertility. The use of
sperm from anonymous donors in cases
of male infertility is currently accepted
by society. However, allogeneic stem
cell transplantation from anonymous012 Elsevier Inc.donors would undoubtedly raise new
ethical issues. In addition, stem cell dona-
tion could have additional health benefits
over sperm donation if recovery of
spermatogenesis after transplantation is
sufficient to conceive naturally, thus
bypassing ART, which is far from being
achieved. The work of Hermann et al.
constitutes a milestone in the field of
reproduction and generates hope for
restoring fertility in survivors of childhood
cancer. Overall, the breakthroughs in
reproductive science, which are pushing
limits further and further, should be
accompanied by intense debates in
society to contend with ethical issues
and to define firm safeguards for clinical
applications.REFERENCES
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